Prenylated phenolics from Morus alba against MRSA infections as a strategy for wound healing

被引:8
作者
Skovranova, Gabriela [1 ,2 ]
Culenova, Marie [1 ]
Treml, Jakub [2 ]
Dzuricka, Lucia [3 ]
Marova, Ivana [3 ]
Sychrova, Alice [1 ]
机构
[1] Masaryk Univ, Fac Pharm, Dept Nat Drugs, Brno, Czech Republic
[2] Masaryk Univ, Fac Pharm, Dept Mol Pharm, Brno, Czech Republic
[3] Brno Univ Technol, Fac Chem, Inst Food Sci & Biotechnol, Brno, Czech Republic
关键词
antibacterial activity; antimicrobial resistance; kuwanon C; MRSA; mulberry; prenylated phenolics; synergy; wound healing; RESISTANT STAPHYLOCOCCUS-AUREUS; NORA EFFLUX PUMP; ALBA; FLAVONOIDS; INHIBITORS;
D O I
10.3389/fphar.2022.1068371
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antimicrobial resistance is a public health threat and the increasing number of multidrug-resistant bacteria is a major concern worldwide. Common antibiotics are becoming ineffective for skin infections and wounds, making the search for new therapeutic options increasingly urgent. The present study aimed to investigate the antibacterial potential of prenylated phenolics in wound healing. Phenolic compounds isolated from the root bark of Morus alba L. were investigated for their antistaphylococcal potential both alone and in combination with commonly used antibiotics. The minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) were determined by microdilution and agar method. Synergy was investigated using the checkerboard titration technique. Membrane-disrupting activity and efflux pump inhibition were evaluated to describe the potentiating effect. Prenylated phenolics inhibited bacterial growth of methicillin-resistant Staphylococcus aureus (MRSA) at lower concentrations (MIC 2-8 mu g/ml) than commonly used antibiotics. The combination of active phenolics with kanamycin, oxacillin, and ciprofloxacin resulted in a decrease in the MIC of the antimicrobial agent. Kuwanon C, E, T, morusin, and albafuran C showed synergy (FICi 0.375-0.5) with oxacillin and/or kanamycin. Prenylated phenolics disrupted membrane permeability statistically significantly (from 28 +/- 16.48% up to 73 +/- 2.83%), and membrane disruption contributes to the complex antibacterial activity against MRSA. In addition, kuwanon C could be considered an efflux pump inhibitor. Despite the antibacterial effect on MRSA and the multiple biological activities, the prenylated phenolics at microbially significant concentrations have a minor effect on human keratinocyte (HaCaT) viability. In conclusion, prenylated phenolics in combination with commonly used antibiotics are promising candidates for the treatment of MRSA infections and wound healing, although further studies are needed.
引用
收藏
页数:13
相关论文
共 56 条
  • [1] Prenylated phenolics as promising candidates for combination antibacterial therapy: Morusin and kuwanon G
    Aelenei, Petruta
    Rimbu, Cristina Mihaela
    Horhogea, Cristina Elena
    Lobiuc, Andrei
    Neagu, Anca-Narcisa
    Dunca, Simona Isabela
    Motrescu, Iuliana
    Dimitriu, Gabriel
    Aprotosoaie, Ana Clara
    Miron, Anca
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2020, 28 (10) : 1172 - 1181
  • [2] Herbal medicines to the treatment of skin and soft tissue infections: advantages of the multi-targets action
    Amparo, Tatiane Roquete
    Seibert, Janaina Brandao
    de Abreu Vieira, Paula Melo
    Medeiros Teixeira, Luiz Fernando
    Henrique dos Santos, Orlando David
    Bianco de Souza, Gustavo Henrique
    [J]. PHYTOTHERAPY RESEARCH, 2020, 34 (01) : 94 - 103
  • [3] [Anonymous], 2000, CLIN MICROBIOL INFEC, V6, P503
  • [4] [Anonymous], 2015, M07-A10
  • [5] Methods for Dilution Antimicrobial Susceptbility Testing for Bacteria That Grow Aerobically
  • [6] Approved Standard-Tenth Edition
  • [7] Methods for in vitro evaluating antimicrobial activity: A review
    Balouiri, Mounyr
    Sadiki, Moulay
    Koraichi Ibnsouda, Saad
    [J]. JOURNAL OF PHARMACEUTICAL ANALYSIS, 2016, 6 (02) : 71 - 79
  • [8] Centers for Disease Control and Prevention, 2019, ANTIBIOTIC RESISTANC, DOI 10.15620/cdc:82532
  • [9] Phytochemistry, pharmacology, and clinical trials of Morus alba
    Chan, Eric Wei-Chiang
    Lye, Phui-Yan
    Wong, Siu-Kuin
    [J]. CHINESE JOURNAL OF NATURAL MEDICINES, 2016, 14 (01) : 17 - 30
  • [10] Cheesman Matthew J, 2017, Pharmacogn Rev, V11, P57, DOI 10.4103/phrev.phrev_21_17